News
Back to Careers
Juvena’s JUV-161 awarded US orphan drug designation for myotonic dystrophy type 1
Home
Platform
Disease Indications
Pipeline
Team
Join Us
News
Contact Us
Home
Platform
Disease Indications
Pipeline
Team
Join Us
News
Contact Us